ciprofloxacin has been researched along with Emesis in 10 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Excerpt | Relevance | Reference |
---|---|---|
"We conducted a double-blind, randomized trial comparing the equivalence of azithromycin and ciprofloxacin (each given in a single 1-g dose of two 500-mg tablets) among 195 men with severe cholera caused by Vibrio cholerae O1 or O139." | 5.12 | Single-dose azithromycin for the treatment of cholera in adults. ( Ahmed, S; Bennish, ML; Karim, MM; Khan, WA; Saha, D; Salam, MA, 2006) |
"While acute pancreatitis is among the differential diagnosis for elevated lipase levels, several other causes of elevated lipase levels have been identified including several reports Salmonella species as a causative agent." | 1.46 | Salmonella colitis as an unusual cause of elevated serum lipase. ( Buchan, D; Dean, R; Gill, D, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (50.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kawasaki, Y | 1 |
Matsubara, K | 1 |
Takahashi, H | 1 |
Morita, M | 1 |
Ohnishi, M | 1 |
Hori, M | 1 |
Isome, K | 1 |
Iwata, A | 1 |
Nigami, H | 1 |
Ikemachi, M | 1 |
Yamamoto, G | 1 |
Ohkusu, K | 1 |
Dean, R | 1 |
Gill, D | 1 |
Buchan, D | 1 |
Saha, D | 1 |
Karim, MM | 1 |
Khan, WA | 1 |
Ahmed, S | 1 |
Salam, MA | 1 |
Bennish, ML | 1 |
Myers, AL | 1 |
Colombo, J | 1 |
Jackson, MA | 1 |
Harrison, CJ | 1 |
Roberts, CR | 1 |
Cohen, H | 1 |
Francisco, DH | 1 |
Parry, H | 1 |
Howard, AJ | 1 |
Galpin, OP | 1 |
Hassan, SP | 1 |
James, AH | 1 |
Katz, VL | 1 |
Dotters, DJ | 1 |
Rogers, RG | 1 |
Stahlmann, R | 1 |
Maher, D | 1 |
Chiu, J | 1 |
Nussbaum, J | 1 |
Bozzette, S | 1 |
Tilles, JG | 1 |
Young, LS | 1 |
Leedom, J | 1 |
Heseltine, PN | 1 |
McCutchan, JA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Randomized, Double-Blind, Controlled Clinical Trial to Compare Efficacy of a Single Dose of Azithromycin Versus a Single Dose of Ciprofloxacin in the Treatment of Adults With Clinically Severe Cholera Due to V. Cholerae O1 or O139[NCT00229944] | Phase 3 | 220 participants | Interventional | 2002-12-31 | Completed | ||
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Two-Part Trial to Evaluate the Efficacy, Safety, and Tolerability of iOWH032 in the Treatment of Acute Dehydrating Diarrhea in Adult and Pediatric Patients With Cholera[NCT02111304] | Phase 2 | 0 participants (Actual) | Interventional | 2014-06-30 | Withdrawn (stopped due to Trial was never initiated due to PATH executive decision.) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 trials available for ciprofloxacin and Emesis
Article | Year |
---|---|
Single-dose azithromycin for the treatment of cholera in adults.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bangladesh; Cholera; Ciprofloxacin; Combined Modality Th | 2006 |
Single-dose azithromycin for the treatment of cholera in adults.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bangladesh; Cholera; Ciprofloxacin; Combined Modality Th | 2006 |
Single-dose azithromycin for the treatment of cholera in adults.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bangladesh; Cholera; Ciprofloxacin; Combined Modality Th | 2006 |
Single-dose azithromycin for the treatment of cholera in adults.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bangladesh; Cholera; Ciprofloxacin; Combined Modality Th | 2006 |
The prophylaxis of travellers' diarrhoea; a double blind placebo controlled trial of ciprofloxacin during a Himalayan expedition.
Topics: Altitude; Ciprofloxacin; Diarrhea; Double-Blind Method; Expeditions; Female; Humans; Male; Mountaine | 1994 |
8 other studies available for ciprofloxacin and Emesis
Article | Year |
---|---|
Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis sequence type 4821: The first case in Japan.
Topics: Anti-Bacterial Agents; Ceftriaxone; Child, Preschool; Ciprofloxacin; Diagnostic Tests, Routine; Drug | 2018 |
Salmonella colitis as an unusual cause of elevated serum lipase.
Topics: Abdominal Pain; Anti-Bacterial Agents; Ciprofloxacin; Colitis; Diagnosis, Differential; Diarrhea; Hu | 2017 |
Tuberculous colitis mimicking Crohn disease.
Topics: Abdominal Pain; Adolescent; Anastomosis, Surgical; Anti-Infective Agents; Antitubercular Agents; App | 2007 |
Twelve-gram overdose of ciprofloxacin with mild symptomatology.
Topics: Abdominal Pain; Adolescent; Ciprofloxacin; Drug Overdose; Humans; Male; Nausea; Vomiting | 1994 |
Clostridium difficile infection in obstetric and gynecologic patients.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; | 1997 |
Clinical toxicological aspects of fluoroquinolones.
Topics: Anti-Infective Agents; Bacterial Infections; Cardiovascular Diseases; Central Nervous System Disease | 2002 |
A problem with oral rifampicin in the prophylaxis of meningococcal infection.
Topics: Administration, Oral; Ciprofloxacin; Humans; Infant; Male; Meningococcal Infections; Penicillins; Ri | 1991 |
Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Amikacin; Chemical and Drug Induced Liver | 1990 |